| Code | 4402A | ||||||||||
| MA number | 31/0090/13-S | ||||||||||
| Product Form: | tbl 7x10 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 11.03.2013 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Ezetimibe Sandoz 10 mg_09.2023.pdf
|
| SPC: |
SPC_Ezetimibe Sandoz 10 mg_09.2023.pdf
|
| Safety feature | Yes |
| Data update: | 16.01.2018 |
